Hospital Acquired Pneumonia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
The global hospital acquired pneumonia treatment market is estimated to value over US$ 1.5 billion with a CAGR of 3% during the forecast period, 2019 to 2026In the recent past, the public healthcare system is facing a difficult challenge in the form of Hospital Acquired Pneumonia (HAP). It is a type of pneumonia when a person is hospitalized for more than 48 hours. In pneumonia, the lungs are conditioned to an inflammatory state which affects alveoli which are microscopic air sacs. One of the primary reasons that patients acquire HAP is by bacteria, viruses and some other organisms. The distinguishing factor is the manner in which the infection is acquired. Another reason for acquiring HAP is the rise in the geriatric population across the world due to which the hospital stays become lengthy increasing the chances of getting acquired by pneumonia. The HAP is prevalent among patients who are immunocompromised and who have undergone surgery. It is also found primarily among newborn babies as they are highly probable of acquiring nosocomial pneumonia due to Respiratory Syncytial Virus (RSV). The overall occurrence of HAP in the U.S is around 1.6% i.e. 3.63 per 1000 patients. There is an ever-increasing demand for HAP drugs because of an unhealthy environment in hospitals along with a poor hospital infrastructure in developing economies. Due to the presence of a large number of vendors, the overall HAP drug market is pretty much splintered. Very few vendors are in favour of adopting pricing strategies that will increase the market competition. Companies are likely to embrace high investment strategies to adopt newer research and development programs, advanced technologies, acquisitions and mergers to strengthen their market position.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=197&page=requestsample
Insights on Global HAP Treatment Market:
1. By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the world
North America and Europe dominate the global HAP treatment market. Out of the two, North America is the most dominant and the major shareholder is the U.S due to a well-established and highly advanced healthcare system and it is expected that they will perform the same during the forecast period. The market in the European region is primarily dominated by UK, France, Germany and Italy. The most promising market space for manufacturers in today’s time is the Asia Pacific due to very high prevalence. Along with that, positive changes in healthcare policies will lead to robust market growth in the Asia Pacific. Rest of the world and Latin America are also fast-growing markets due to changing healthcare policies and an increasing incidence.
2. By End User
• Hospitals
• Retail pharmacies
Hospital segment effortlessly dominated the global HAP treatment market and is likely to do so during the forecast period and the primary reasons are better infrastructural facilities as compared to retail pharmacies who have a limited infrastructure which hampers their market growth.
3. By Drug Type
• Tazobactam
• Cefepime
• Levofloxacin
• Imipenem
• Meropenem
Purchase a Copy of this Premium Research Report At: https://www.futurewiseresearch.com/pressrelease/Global-Hospital-Acquired/137
Competitive Landscape:
• GlaxoSmithKline
• Merck Inc.
• Pfizer Inc.
• Bayer Healthcare
• Novartis Inc.
• Sun pharmaceutical
• Teva pharmaceutical
Pfizer has data from a phase 3 clinical trial which shows how effective is their antibiotic Zavicefta and such positive results will help them gain a significant amount of market during the forecast period. Bayer Healthcare has partnered with Cubist pharmaceutical Inc. and co-developed Sivextro which is an antibiotic for HAP treatment and this partnership will be crucial for increasing their market share during the forecast period and in turn strengthen their market position.
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global hospital acquired pneumonia treatment market by region, by end user, by drug type
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Inquire further details about this report at: sales@futurewiseresearch.com
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: sales@futurewiseresearch.com
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hospital Acquired Pneumonia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 here
News-ID: 1787173 • Views: …
More Releases from FutureWise Research
Unit Drug Dose Delivery System Market Global Trends, Market Share, Industry Size …
Global Unit Drug Dose Delivery System Market is poised to register a CAGR of over 5% during the forecast period of 2019 to 2026.
Patients have to receive accurate dosing of drugs which will improve the recovery rate of the patient hence unit drug delivery system is implemented by hospitals and clinics. This system is also efficient in maintaining drug storage and its disposal. These are some of the primary factors that…
Vascular Sealing Systems Market Global Trends, Market Share, Industry Size, Grow …
Global vascular sealing systems market predicted to value over USD 1 billion by 2026 end and register a CAGR over 6% during the forecast period 2019 to 2026.
The number of patients experiencing cardiovascular disease (CVD) are on a rise due to lack of physical activity, high blood pressure, changing lifestyle, addictions like alcohol consumption and smoking. According to the American Heart Association, CVD is the leading cause for mortality worldwide,…
Implantable Pulse Generator Market Global Trends, Market Share, Industry Size, G …
A rise in various complex diseases and medical conditions has led the healthcare sector to push research and development boundaries which have resulted in a new age of disease treatment and one such technology is Implantable Pulse Generator (IPG). It is a micro-electronic medical device which is battery-powered that is inserted in the body where the nervous system is delivered with an electric stimulation which helps in stimulation or blocking…
Mining Equipment Market Global Trends, Market Share, Industry Size, Growth, Oppo …
Comprehensive analysis of data on Mining Equipment Market by FutureWise Market Research offers in-depth research targeting prevailing market trends impacting the business across different regions. Vital aspects related to market share, market size, applications and statistics are consolidated to illustrate an aggregate forecast of the mining industry. The study further focuses on the competitor's analysis and highlighting growth tactics adopted by market leaders.
Augmentation of existing mining projects along with new mining projects in developing countries…
More Releases for HAP
Hydroxyapatite Hap Market Trends 2021 | Segmentation, Outlook, Industry Report t …
The Hydroxyapatite Hap Market size is expected to grow at an annual average of 5% during 2021-2027. Hydroxyapatite (HA) is a major component of normal bone and teeth already used as a coating for orthopedic implants to anchor and promote bone growth. Growing demand for dental and orthopedic implants along with growing popularity of bioactive materials and strong investment in R&D activities to expand the application of hydroxyapatite are expected…
Hydroxyapatite (HAp) Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Hydroxyapatite (HAp) analysis, which studies the Electrical Cord Reels's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Hydroxyapatite (HAp) 2020-2025” Research Report categorizes the global Hydroxyapatite (HAp) by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth rate, opportunities…
Hydroxyapatite Hap Market, Industry Share, Trends, Growth, Future Prospects, For …
The Hydroxyapatite (HAp) market is expected to grow by 6.5% CAGR from 2019 to 2025, growing from $2.2 billion in 2019 to $3.1 billion in 2025.
Hydroxyapatite (HAp) is a mineral present in the bones and hard tissues of humans and animals. The micro-sized hydroxyapatite (HAp) can be designed using nanotechnology applicable to orthopedic surgery and drug delivery systems. It is mainly used for various bone graft methods, and is also…
Global Hospital-Acquired Pneumonia (HAP) Drugs Market 2019 - Teva Pharmaceutical …
HAP is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of the major challenges faced by the public healthcare system today. The disease is the second most common type of hospital-acquired infections. Pneumonia is an inflammatory condition of lungs and mainly affects the microscopic air sacs called alveoli. This is primarily caused by infection by bacteria or viruses and sometimes with other microorganisms.…
Hydroxyapatite Market (HAp) 2018 Global Industry Trends, Share, Size and 2023 Fo …
2018-2023 Hydroxyapatite Market (HAp) research report presents a comprehensive study of the Hydroxyapatite Market in Global Industry; the study scans the progression of the market trailed over the past few years and the forecasts of growth in the coming years, primarily in terms of sales. The research report highlights the reasons liable for the disparities in the market and investigates them methodically. The Hydroxyapatite Market (HAp) effect factors have also…
Global Hospital-acquired Pneumonia (HAP) Drugs Market Outlook 2017-2021
The study of Hospital-acquired Pneumonia (HAP) Drugs Market in UK 2017-2021 industry is very important to enhance business productivity and for the study of market forecast. This New Report presented by Orbis Reseach contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Hospital-acquired Pneumonia (HAP) Drugs is a type of pneumonia that is caused after 48 hours of hospitalization. HAP is one of…